The benefit set by the French Haute Autorité de Santé (HAS) is a criterion which takes into account: the seriousness of the pathology for which the medicine is indicated; and the data specific to the drug itself in a given indication.

Haute Autorité de Santé (HAS) | DiMe’s 3Ps of Digital Endpoint Value